Navidea Biopharma (NAVB) Appoints Dr. Michael Rosol as CMO
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) , a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)